Open AccessPain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
Author(s) -
Vibeke Strand,
Atul Deodhar,
Rieke Alten,
Emma Sullivan,
S. Blackburn,
Haijun Tian,
Kunal K. Gandhi,
SM Jugl,
Philip G. Conaghan
Publication year - 2020
Publication title -
journal of clinical rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.615
H-Index - 50
eISSN - 1536-7355
pISSN - 1076-1608
DOI - 10.1097/rhu.0000000000001544
Subject(s) - medicine , ankylosing spondylitis , basdai , visual analogue scale , quality of life (healthcare) , physical therapy , depression (economics) , disease , nursing , psoriatic arthritis , economics , macroeconomics
Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-world, global survey was conducted among AS patients receiving tumor necrosis factor inhibitors (TNFis) to evaluate both the frequency and severity of persistent symptoms, and the impact of pain and fatigue on HRQoL, employment status, and work activity.